Dacarbazine for malignant melanoma.
D000577:Amides / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy*; D014226:Triazenes / Q000009:adverse effects / Q000627:therapeutic use*
D000577:Amides; D000970:Antineoplastic Agents; D007093:Imidazoles; D014226:Triazenes